Drug targeting through pilosebaceous route

Current Drug Targets

Volumn 10, Issue 10, 2009, Pages 950-967

  Chourasia, Rashmi ^a   Jain, Sanjay K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Delivery systems; Hair follicle; Nanostructured lipid carriers; Pilosebaceous unit; Sebaceous gland

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 4 [3 (4 HYDROXYBUTYL) 4,4 DIMETHYL 2,5 DIOXO 1 IMIDAZOLIDINYL] 2 TRIFLUOROMETHYLBENZONITRILE; ADAPALENE; ALPHA INTERFERON; ALPHA2 INTERFERON; ANTIANDROGEN; CALCEIN; CARBOXYFLUORESCEIN; CIMETIDINE; CYCLOSPORIN; DOXORUBICIN; ECONAZOLE; FINASTERIDE; FLUORESCEIN ISOTHIOCYANATE; INULIN; ISOTRETINOIN; LIPOSOME; MELANIN; METHYLENE BLUE; MICROSPHERE; MINOXIDIL; NANOCARRIER; NANOPARTICLE; NIOSOME; PHOSPHATIDYLCHOLINE; POLYOXYETHYLENE STEARYL ETHER; RHODAMINE 6G; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINERYT;

ACNE; ALOPECIA; CELL TRANSPORT; CELL TYPE; CONTACT DERMATITIS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG PENETRATION; DRUG TARGETING; GENE THERAPY; HAIR FOLLICLE; HAIR GROWTH; HIRSUTISM; HUMAN; HYPERTENSION; HYPERTRICHOSIS; ICHTHYOSIS; IONTOPHORESIS; KERATOSIS; MALIGNANT NEOPLASTIC DISEASE; PROPIONIBACTERIUM ACNES; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; SEBACEOUS GLAND; SEBORRHEIC DERMATITIS; SKIN ALLERGY; SKIN APPENDAGE; SKIN CANCER; SKIN DISEASE; SKIN PENETRATION; TRANSCYTOSIS;

ADMINISTRATION, TOPICAL; ANIMALS; COSMETICS; DRUG DELIVERY SYSTEMS; GENE THERAPY; HAIR FOLLICLE; HUMANS; SEBACEOUS GLANDS; SKIN ABSORPTION; SKIN DISEASES;

EID: 70450174442     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945009789577918     Document Type: Review

References (141)

1. Singh P, Sihorkar V, Jaitely V, Kanaujia P, Vyas SP. Pilosebaceous unit: Anatomical considerations and drug delivery oppurtunities. Indian Pharmacol 2000; 32: 269-281. (Pubitemid 30827028)
2. Lademann J, Otberg N, Richter H, Jacobi U, Schaefer H, Blume-Peytavi U. Follikuläre Penetration - Ein entscheidender Penetrationsweg von topisch applizierten Substanzen. Hautarzt 2003; 54: 321-323. (Pubitemid 36753097)
3. Schaefer H, Lademann J. The Role of follicular penetration-a differential view. Skin Pharmacol Appl Physiol 2001; 14(suppl 1): 23-27. (Pubitemid 34299160)
4. MacKee GM, Sulzberger MB, Herrmann F, Baer RL. Histologic studies on percutaneous penetration with special reference to the effect of vehicles. J Invest Dermatol 1945; 6: 43-61.
5. Montagna W. Penetration and local effect of vitamin A on the skin of the guinea pig. Proc Sot Exp Biol Med 1954; 86: 668-672.
6. Scheuplein RJ. Mechanism of percutaneous absorption. J Invest Dermatol 1967; 48: 79-88.
7. Rutherford T, Black JG. The use of autoradiography to study the localization of germicides. Br J Dermatol 1969; XI: 75-87.
8. Scheuplein RJ, Blank HI, Brauner GJ, McFarlane DJ. Percutaneous absorption of steroids. J Invest Dermatol 1969; 52: 63-70.
9. Feldmann RJ, Maibach HI. Regional variation in percutaneous penetration of "C-cortisol in man. J Invest Dermatol 1967; 48: 181-183.
10. Illel B, Schaefer H. Transfollicular percutaneous absorption-Skin model for quantative studies. Acta Derm Venereol (Stockh) 1988; 68: 427-457. (Pubitemid 18230270)
11. Illel B, Schaefer H, Wepierre J, Doucet O. Follicles play an important role in percutaneous absorption. Pharm Sci 1991; 80: 424-427.
12. Lieb LM, Liimatta AP, Bryan RN, Krueger GG. Description and definition of a transfollicular route of permeant for topically applied agents to human scalp skin. J Invest Dermatol 1995; 104: 655.
13. Li L, Hoffman RM. The feasibility of targeted selective gene therapy of the hair follicle. Nat Med 1995; 1: 705-706.
14. Lieb LM, Ramachandran C, Egbaria K, Weiner N. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the Hamster ear model. J Invest Dermatol 1992; 99: 108-113.
15. Li L, Lishko VK, Margolis LB, Hoffman RM. Product-delivering liposomes specifically target hair follicles in histocultured intact skin. In Vitro Cell Dev Biol 1992; 28A: 679-681. (Pubitemid 23054031)
16. Li L, Lishko VK, Hoffman RM. Liposomes can specifically target entrapped melanin to hair follicles in histocultured skin. In Vitro Cell Dev Biol 1993; 29A: 192-194. (Pubitemid 23123704)
17. Li L, Lishko VK, Hoffman RM. High efficiency liposome-mediated transfection of the tyrosinase gene to cultured cells: A model for the gene therapy of hair color restoration. In Vitro Cell Dev Biol 1994; 30A: 135-138.
18. Du Plessis J, Egbaria K, Ramachandran C, Weiner N. Topical delivery of liposomally encapsulated gamma-interferon. Antiviral Res 1992; 18: 259-265.
19. Niemiec SM, Ramachandran C, Weiner N. Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: An in vivo study using the hamster ear model. Pharm Res 1995; 12: 1184-1188.
20. Fleisher D, Niemiec SM, Oh CK, Hu Z, Ramachandran C, Weiner N. Topical delivery of growth hormone releasing peptide using liposomal systems: an in vitro study using hairless mouse skin. Life Sci 1995; 57: 1293-1297.
21. Domashenko A, Cotsarelis G. Transfection of human hair follicles using topical liposomes is optimal at the onset of anagen. J Invest Dermatol 1999; 112: 552-554
22. Domashenko A, Gupta S, Cosartelis G. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol 2000; 18: 420-423. (Pubitemid 30217530)
23. Rolland A, Wagner N, Chatelus A, Shroot B, Schaefer H. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Res 1993; 10: 1738-1744. (Pubitemid 24000358)
24. Lademann J, Weigmanna HJ, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny Layer and the Follicular Orifice. Skin Pharmacol Appl Skin Physiol 1999; 12: 247-256. (Pubitemid 29401452)
25. Mordon S, Sumian C, Devoisselle JM. Site specific Methylene blue delivery to pilosebaceous structures using highly porous nylon microspheres. Lasers Surg 2003; 33: 119-125.
26. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004; 99: 53-62. (Pubitemid 39165733)
27. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004; 21: 1818-1825. (Pubitemid 39390094)
28. Lieb LM, Flynn G, Weiner N. Follicular (pilosebaceous unit) deposition and pharmacological behavior of cimetidine as a function of formulation. Pharm Res 1994; 11: 1419-1423. (Pubitemid 24339648)
29. Lingna Li, Hoffman RM. Topical liposome delivery of molecules to hair follicles in mice. Dermatol Sci 1997; 14: 101-108.
30. Bernard E, Dubois JL, Wepierre J. Percutaneous absorption of a new antiandrogen included in liposomes or in solution. Intl Pharm 1995; 126: 235-243. (Pubitemid 26018579)
31. Bernard E, Dubois JL, Wepierre J. Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. J Pharm Sci 1997; 86: 573-578. (Pubitemid 27203404)
32. Koichiro T, Yuri O, Tatsuo Y, Hitoshi M, Minoru I. Liposome as an excellent DDS for hair growing products. SCCJ 1998; 32: 345-352.
33. Tschan T, Steffen H, Supersaxo A. Sebaceous-gland deposition of isotretinoin after topical application: an in vitro study using human facial skin. Skin Pharmacol 1997; 10: 126-134.
34. Han I, Kim M, Kim J. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis. Exper Dermatol 2004; 13: 86-92. (Pubitemid 38247866)
35. Lieb ML, Limatta AP, Bryan RN, Brown BD, Krueger GG. Description of the intrafollicular delivery of large molecular weight molecules to follicles of human scalp skin in vitro. J Pharm Sci 1997; 86: 1022-1029.
36. Yarosh D, Bucana C, Cox P, Alas L, Kibitel J, Kripke M. Localization of liposomes containing a DNA repair enzyme in murine skin. J Invest Dermatol 1994; 103: 461-468. (Pubitemid 24314828)
37. Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouza S. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006; 323: 1-10.
38. Morgan AJ, Lewis G, Van Den Hoven WE, Akkerboom PJ. The effect of zinc in the form of erythromycin-zinc complex (Zineryt lotion) and zinc acetate on metallothionein expression and distribution in hamster skin. Br Dermatol 1993; 129: 563-570. (Pubitemid 23336453)
39. Schaefer H, Watts F, Brod J, Illel B. In: Scott, R.C., Guy, R.H., Hadgraft, J. (Eds.), Prediction of percutaneous penetration: Methods, measurements, and modelling, IBC Technical Services, London, 1990; 163-173.
40. Sumian CC, Pitre FB, Gauthier BE, Bouclier M, Mordon SR. A new method to improve penetration depth of dyes into the follicular duct: potential application for laser hair removal. J Am Acad Dermatol 1999; 41: 172-175. (Pubitemid 29379699)
41. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume- Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 2004; 123: 168-176. (Pubitemid 38833478)
42. Shim J, Kang SH, Park WS, Han SH, Kim J, Chang IS. Transdermal delivery of minoxidil with block copolymer nanoparticles. J Control Release 2004; 97: 477-484. (Pubitemid 38802949)
43. Wu H, Ramachandran C, Weiner ND, Roessler BJ. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Intl Pharm 2001; 220: 63-75. (Pubitemid 32476842)
44. Wu H, Ramachandran C, Bielinska AU, Kingzett K, Sun R, Weiner ND, Roessler BJ. Topical transfection using plasmid DNA in a water-in-oil Nanoemulsion. Int Pharm 2001; 221: 23-34. (Pubitemid 32524032)
45. Munster U, NakamuraNachname C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis CC, Blume-Peytavi U, Schafer-Korting M. RU 58841-myristate-prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie 2005; 60: 8-12.
46. Odland GF. Structure of the skin. In: L.A. Goldsmith (Ed.). Biochemistry and physiology of the skin. Oxford University Press Oxford. 1985; 3-63.
47. Strauss JS, Dowing DT, Ebling FJ. In: Biochemistry and physiology of the skin, New York, Oxford University Press. 1983; 569-592.
48. Greene RS, Downing DT, Pochi PE, Strauss JS. Anatomical variation in the amount and composition of human skin surface lipid. J Invest Dermatol 1970; 54: 240-247.
49. Stenn KS. Insights from the asebia mouse: a molecular sebaceous gland defect leading to cicatricial alopecia. J Cutaneous Pathol 2001; 28: 445-447.
50. Schaefer H, Redelmeier TE. Skin Barrier: Principles of Percutaneous Absorption. Karger Basel. 1996.
51. Meidan VM, Bonner MC, Michniak BB. Transfollicular drug delivery-Is it a reality? Intl J Pharm 2005; 306: 1-14.
52. Poblet E, Ortega F, Jimenez F. The arrector pili muscle and the follicular unit of the scalp: a microscopic anatomy study. Dermatol Surg 2002; 28: 800-803. (Pubitemid 35014681)
53. Kealey T, Philpott M, Guy R. The regulatory biology of the human pilosebaceous unit. Bailli&e's Clin Obstet Gynaecol 1997; 11: 205-227. (Pubitemid 27353113)
54. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999; 341: 491-497.
55. Uno H. Quantitative models for the study of hair growth in vivo. Ann N Y Acad Sci 1991; 642: 107-124.
56. Chase HB, Eaton GJ. The growth of hair follicles in waves. Ann N Y Acad Sci 1959; 83: 365-368.
57. Bullough WS. Mitotic control in mammalian tissues. Biol Res 1975; 50: 98-127.
58. Sutton R, Cam GR, Ward WG, Raphael KA, Ward KA. Proto-oncogenes of wool and hair growth. Ann N Y Acad Sci 1991; 642: 321-338
59. Philpott MP, Green MR, Kealey T. Human hair growth in vitro. J Pharm Sci 1990; 97: 463-471
60. Hardy MH. The secret life of the hair follicle. Trends Genet 1992; 8: 55-61.
61. Cotsarelis G, Sun T, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle and skin carcinogenesis. Cell 1990; 61: 1329-1337 (Pubitemid 20208836)
62. Valiveti S, Wesley J, Lu GW. Investigation of drug partition property in artificial sebum. Intl J Pharm 2008; 346: 10-16. (Pubitemid 350101987)
63. Steinstrasser I, Merkle HP. Dermal metabolism of topically applied drugs: Pathways and models reconsidered. Pharm Acta Helvetiae 1995; 70: 3-24
64. Lademann J, Otberg N, Richter H, Weigman HJ, Lindemann U, Schaefer H, Sterry W. Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 2001; 14 : 17-22. (Pubitemid 34299159)
65. Jahoda CAB, Horne KA, Oliver RF. Induction of hair growth by implantation of cultured dermal papilla cells. Nature 1984; 311: 560-562. (Pubitemid 14046378)
66. Messenger AG. The culture of dermal papilla cells from human hair follicles. Br J Dermatol 1984; 110: 685-689. (Pubitemid 14084051)
67. Limat A, Hunziker T, Waelti E, Inaebrit S, Wiesmann U, Braethen LR. Soluble factors from human hair papilla cells and dermal fibroblasts dramatically increase the clonal growth of outer root sheath cells. Arch Dermatol Res 1993; 285: 205-210. (Pubitemid 23210104)
68. Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano AM, Jahoda CAB. Trans-gender induction of hair follicles. Nature 1999; 402: 33-34.
69. Jahoda CAB, Reynolds AJ. Dermal-epidermal interactions. Adult-derived follicle populations and hair growth. In: Whiting DA (ed). Philadelphia, W.B. Saunders Press. 1996; 573-583.
70. Matsuzaki T, Yoshizato K. Role of hair papilla cells on induction and regeneration processes of hair follicles. Wound Repair Regen 1998; 6: 524-530. (Pubitemid 128659200)
71. Kondo S, Hozumi Y, Aso K. Organ culture of human scalp hair follicles: Effect of testosterone and oestrogen on hair growth. Arch Dermatol Res 1990; 282: 442-445. (Pubitemid 20350065)
72. Buhl AE, Waldon DJ, Kawabe TT, Holland JM. Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol 1989; 92: 315-320.
73. Thornton MJ, Thomas DJ, Brinklow BR, Loudon ASI, Randall VA. Testosterone or IGF-I stimulates hair growth in whole organ culture only in androgendependent red deer follicles In: Van Neste D, Randall VA (eds.) Hair Research for the Next Millenium, Amsterdam, Elsevier Science BV. 1996a; 311-331
74. Ibraheem M, Galbraith H, Scaife J. Growth and viability of secondary hair follicles in the angora goat cultured in vitro. J Anat 1993; 182: 231-238. (Pubitemid 23177596)
75. nd edn). NewYork: Oxford University Press 1991.
76. Porter RM. Mouse models for human hair loss disorders. J Anat 2003; 202: 125-131. (Pubitemid 36503975)
77. Chase HB, Rauch H, Smith VW. Critical stages of hair development and pigmentation in the mouse. Physiol Zol 1951; 24: 1-8.
78. Paus R, Stenn KS, Link RE. The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest 1989; 60: 365-369. (Pubitemid 19095953)
79. Slominski A, Paus R, Costantino R. Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol 1991; 96: 172-179.
80. Sundberg JP, Beamer WG, Uno H, Van Neste D, King LEJr. Androgenetic alopecia: in vivo models. Exp Mol Pathol 1999; 67: 118-130.
81. Sundberg JP, King LEJr, Bascom C. Animal models for male pattern (androgenetic) alopecia. Eur J Dermatol 2001; 11: 321-325. (Pubitemid 32623328)
82. Matias JR, Malloy V, Orentreich N. Animal models of androgen-dependent disorders of the pilosebaceous apparatus. Arch Dermatol Res 1989; 281: 247-253.
83. Uno H, Imamura K, Pan H. Androgenetic alopecia in the stump-tailed macaque. An important model for investigating the pathology and antiandrogenetic therapy of male pattern baldness In: Camacho F, Randall VA, PriceV (eds). Hair and its Disorders: Biology, Pathology and Management, London, Martin Dunitz. 2000; 137-151.
84. Osborne DW, Hatzenbuhler DA. The influence of skin surface lipids on topical formulations. In: Osborne DW. Amann, A.H. (Eds.), Topical Drug Delivery Formulations, Marcel Dekker, New York 1990; 69-85.
85. Barry BW. Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 2002; 54: S31-S40.
86. Frum Y, Bonner MC, Eccleston GM, Meidan VM. The influence of drug partition coefficient on follicular penetration: In vitro human skin studies. Eur J Pharm Sci 2007; 30: 280-287.
87. Maia CS, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schafer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002; 10: 489-495. (Pubitemid 35230199)
88. Cullander C, Guy RH. Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode. J Invest Dermatol 1991; 97: 55-64.
89. Green PG, Hinz RS, Kim A, Szoka FC, Guy RH. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm Res 1991; 8: 1121-1127.
90. Balsari AL, Morelli D, Menard S, Veronesi U, Colnaghi MI. Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies. FASEB J 1994; 8: 226-230. (Pubitemid 24985943)
91. Lauer AC, Lieb LM, Ramachandran C, Flynn GL, Weiner N. Transfollicular drug delivery. Pharm Res 1995; 12: 179-186.
92. Lauer AC, Ramachandran C, Lieb LM, Niemiec SM, Weiner N. Targeted delivery to the pilosebaceous unit via liposomes. Adv Drug Deliv Rev 1996; 18: 311-324.
93. Niemiec SM, Ramachandran C, Weiner N. Perifollicular transgenic expression of human interlukin-1 receptor antagonist protein following topical application. J Pharm Sci 1997; 86: 701-708.
94. Weiner N. Targeted follicular delivery of macromolecules via liposomes. Intl J Pharm 1998; 162: 29-38.
95. Stracke F, Weiss B, Lehr CM, Konig K, Schaefer UF, Schneider M. Multiphoton microscopy for the investigation of dermal penetration of nanoparticle-borne drugs. J Invest Dermatol 2006; 126(10): 2224-2233. (Pubitemid 44413169)
96. Schenke-Layland K, Riemann I, Damour O, Stock UA, Konig K. Two-photon microscopes and in vivo multiphoton tomographs - Powerful diagnostic tools for tissue engineering and drug delivery. Adv Drug Deliv Rev 2006; 58(7): 878-896.
97. Mezei M, Gulasekharam V. Liposomes: a selective drug delivery system for the topical route of administration: I: lotion dosage form. Life Sci 1980; 26: 1473-1477.
98. Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2005; 2: 67-74.
99. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004; 56: 675-711. (Pubitemid 38326939)
100. Song YK, Kim CK. Topical delivery of low-molecular weight heparin with surface-charged flexible liposomes. Biomaterials 2006; 27: 271-280.
101. Hoffmann RM. Topical liposome targeting of dyes, melanins, genes and proteins selectively to hair follicles. J Drug Target 1997; 5: 67-74.
102. Jung S, Otberg N, Thiede G, Richter H, Sterry W, Panzner S, Lademann J. Innovative Liposomes as a transfollicular drug delivery System: Penetration into Porcine Hair Follicles. J Invest Dermatol 2006; 126: 1728-1732. (Pubitemid 44086505)
103. Touitou E, Junginger HE, Weiner ND, Nagai T, Mezei M. Liposomes as carriers for topical and transdermal delivery. Pharm Sci 1994; 83: 1189-1203. (Pubitemid 24282318)
104. Jayaraman SC, Ramachandran C, Weiner N. Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. J Pharm Sci 1996; 85: 1082-1084.
105. Uchegbu IF, Double JA, Turton JA, Florence AT. Distribution, metabolism and tumoricidal activity of doxorubicin administration in sorbitan monostearate (Span 60) niosomes in the mouse. Pharm Res 1995; 12: 1019-1024
106. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Intl J Pharm 1998; 172: 33-70.
107. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001; 228: 43-52.
108. Grams YY, Bouwstra JA. Penetration and distribution of three lipophilic probes in vitro in human skin focusing on the hair follicle. J Control Release 2002; 83: 253-262.
109. Bamba FL, Wepierre J. Role of the appendageal pathway in the percutaneous absorption of pyridostigmine bromide in various vehicles. Eur J Drug Metab Pharmacokinet 1993; 18: 339-348. (Pubitemid 24099779)
110. Osborne DW, Middleton CA, Rogers RL. Alcohol free microemulsions. J Disp Sci Technol 1988; 9: 415-423.
111. Bouchemal K, Briancon S, Perrier E, Fessi H. Nano-emulsion formulation using spontaneous emulsification: solvent, oil & surfactant optimisation. Int J Pharm 2004; 280: 241-251. (Pubitemid 38960674)
112. Fasolo D, Schwingel L, Holzschuh M, Bassani V, Teixeira H. Validation of an isocratic LC method for determination of quercetin and methylquercetin in topical nanoemulsions. J Pharm Biomed Anal 2007; 44: 1174-1177. (Pubitemid 47239297)
113. Wu HL, Ramachandran C, Bielinska AU, Kingzett K, Sun R, Weiner ND, Roessler BJ. Submitted to Molecular Therapy, February 2000.
114. Beck RCR, Pohlmann AR, Hoffmeister C, Gallas MR, Collnot E, Schaefer UF, Guterres SS, Lehr CM. Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers. Eur J Pharm Sci 2007; 67: 18-30.
115. Ourique AF, Pohlmann AR, Guterres SS, Beck RCR. Tretinoin-loaded nanocapsules: Preparation, physicochemical characterization, and photostability study. Intl J Pharm 2008; 352: 1-4.
116. Perugini P, Simeoni S, Scalia S, Genta I, Modena T, Conti B, Pavanetto F. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p methoxycinnamate. Int J Pharm 2002; 246: 37-45. (Pubitemid 35247977)
117. Guterres SS, Alves MP, Pohlmann AR. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights 2007; 2: 1476157.
118. Lademann J, Richter H, Schaefer UF, Blume-Peytavi U, Teichmann A, Otberg N, Sterry W. Hair Follicles - A long-term reservoir for drug delivery. Skin Pharmacol Physiol 2006; 19(4): 232-236. (Pubitemid 44114522)
119. Muller RH, Ruhl D, Runge S, Schulze-Forster K, Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res 1997; 14(4): 458-462. (Pubitemid 27205004)
120. Chen H, Chang X, Du D, Liu W, Liu J, Weng T, Yang Y, Xu H, Yang X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006; 110: 296-306. (Pubitemid 41827483)
121. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001; 47: 165-196. (Pubitemid 32324113)
122. Wissing SA, Muller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study. Eur J Pharm Biopharm 2003; 56: 67-72. (Pubitemid 36802049)
123. Maia CS, Mehnert W, Schafer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 2000; 196: 165-167. (Pubitemid 30105735)
124. Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278: 71-77.
125. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999; 341: 491-497.
126. Parker LN, Lifrak ET, Odell WD. Lack of a gonadal or adrenal androgenic mechanism for the hypertrichosis produced by diazoxide, phenytoin and minoxidil. Biochem Pharmacol 1982; 31: 1948-1950
127. Philpott MP. Defensins and acne. Mol Immunol 2003; 40: 457-462.
128. Thiboutot D. Regulation of human sebaceous glands. J Invest Dermatol 2004; 123: 1-12.
129. Meidan VM, Touitou E. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects. Drugs 2001; 61: 53-69. (Pubitemid 32108323)
130. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47: 377-385
131. Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol 2002; 46: 309-312. (Pubitemid 34118394)
132. Touitou E, Dayan N, Bergelsonb L, Godina B, Eliaza M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. Control Release 2000; 65: 403-418. (Pubitemid 30122942)
133. Jun-Bo T, Zhuang-Qun Y, Xi-Jing H, Ying X, Yong S, Zhe X, Tao C. Effect of ethosomal minoxidil on dermal delivery and hair cycle of C57BL/6 mice. J Dermatol Sci 2007; 45: 135-137. (Pubitemid 46108484)
134. Zelphati O, Szoka FCJr. Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet? Control Release 1996; 41: 99-119.
135. Dokka S, Cooper SR, Kelly S, Hardee GE, Karrasw JG. Dermal delivery of topically applied Oligonucleotides via follicular transport in mouse skin. J Invest Dermatol 2005; 124: 971-975.
136. Balsari AL, Morelli D, Menard S, Veronesi UI, Colnaghi MI. Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies. Res Commun 1994; 8: 226-231.
137. Alexeev V, Igoucheva O, Domashenko A, Cotsarelis G, Yoon K. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA DNA oligonucleotide. Nat Biotechnol 2000; 18: 43-47.
138. Zhao M, Saito N, Li L. A novel approach to gene therapy of albino hair in histoculture with a retroviral Streptomyces tyrosinase gene. Pigment Cell Res 2000; 13: 345-351.
139. Sato N, Leopold PL, Crystal RG. Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog. J Clin Invest 1999; 104: 855-864. (Pubitemid 29536335)
140. Fan H, Lin Q, Morrissey GR, Khavari PA. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 1999; 17(9): 870-872
141. Shaker DS, Sloat BR, Le UM, Lohr CV, Yanasarn N, Fischer KA, Cui Z. Immunization by application of DNA vaccine onto a skin area wherein the hair follicles have been induced into anagen-onset stage. Mol Ther 2007; 15(11): 2037-2043 (Pubitemid 350011744)